Clinical Trial 42156

Tampa, FL 33613


Study Summary:

Study 42156 Flyer
Click image to enlarge

This study is researching a way to minimize risk for children with a peanut allergy who accidentally ingest peanuts with a combination treatment of oral immunotherapy and an investigational product (dupilumab) or placebo in this indication. 

This study will test how dupilumab works in the body, how safe it is to use, and how well it works when added to oral immunotherapy to minimize risk in children who ingest peanuts. 

This study will last between 48 to 72 weeks. 

No health insurance or doctor referral is needed to participate.


Qualified Participants Must:

• Have a history of a peanut allergy
• Be between the ages of 6 to 17 years old
• Have a positive skin prick test
• Meet certain safety laboratory tests
• Pass a peanut food challenge screening procedure


Qualified Participants May Receive:

  • Compensation for time and travel
  • Study-related care at no cost
  • Study medication at no cost 


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.